Skip to content

COBRAMED

Active Private limited companyfounded 1998active for 28 yearsGustave Demanetstraat 87, 1020 BrusselsKBO/BCE: BE 0463.932.093

Lifetime

18 annual accounts with figures on one time axis, 25 filings since 2000
peak of €208,016 in 2010
€12,361▼ 54.3%
lowest -€14,214 in 2018
€1,674▼ 89.1%
peak of €481,150 in 2010
€93,275▼ 5.2%
€19,261▲ 36.7%
Board2 names since 2016
1 director
Documentsfilings and deeds
26-08-202635 days before the deadline
2026micro format
Gross margin from €27,044 to €12,361Result from €15,296 to €1,674Dividend €6,823Debts from €14,091 to €19,261Cash from €33,793 to €21,773

Key points

from the 2026 annual accounts

Equity

€93,275 from €481,150 in 2010

Equity fell by 81% in 16 years.

Turnover

≈ €92,000 estimated

The micro format states no turnover.

Filings

25 annual accounts since 2000
deadline200020102020

The 2020 accounts came 333 days late. The other nine of the last ten were filed on time.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 17,047 companies had the same profile as COBRAMED has now. Each dot stands for 43 companies, two years later.

94.3%
were still trading
5.0%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit under 5% of the balance sheet

Another 0.2% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,047 companies, not a prediction for COBRAMED. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0463932093
Purpose change · Amendment of the articles · Legal-form change · Resignations & appointments “L'exercice de l’art de guérir par les actionnaires qui la composent, lesquels sont exclusivement des médecins…” (deed in French) · Board composition: (director (not named in the articles)) · Legal-form conversion: from private limited company (pre-2019) to private limited company · General meeting of 16-06-2023 · Gazette deed
resigns as manager Director discharge: · General meeting of 05-07-2016 · Gazette deed
Registered office moved from Wemmel to Brussels The registered office moved from Rue Léon Guyot, 58- 1780 Wemmel to Rue Demanet 87, 1020 Bruxelles · General meeting of 13-05-2011 · Gazette deed
All 38 events

Official details

Source: KBO
Status
Active since 24-08-1998Normal situation
Activity
“L'exercice de l’art de guérir par les actionnaires qui la composent, lesquels sont exclusivement…” (deed in French)From the articles, 5 activitiesNo NACE code in the KBO
Financial year end
28 February
Peppol
Reachable since 11-06-2026
Company details

Annual accounts to 28-02-2026

€112,536=
Filing
Filed on 26-08-2026, 35 days before the end of the filing period
Financials

Insights on COBRAMED

COBRAMED files the micro format. That format states no turnover. The gross margin fell from €150,674 in 2007 to €12,361 in 2026.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about COBRAMED

What is the company number of COBRAMED?
The company number of COBRAMED is 0463.932.093. The VAT number is the same number with BE in front: BE 0463.932.093.
Where is COBRAMED based?
The registered office is at Gustave Demanetstraat 87, 1020 Brussels.Company details
What is the legal form of COBRAMED?
COBRAMED is a private limited company (BV).
When was COBRAMED founded?
COBRAMED was founded on 24-08-1998.
Is COBRAMED still active?
Yes, COBRAMED is an active enterprise in the KBO register.
What is the turnover of COBRAMED?
The turnover in financial year 2026 is ≈ €92,000. This figure is estimated from the gross margin of €12,361 and 7,101 comparable companies of the same size. It probably lies between €42,000 and €220,000. It is a rough estimate.Financials
Is COBRAMED profitable?
In financial year 2026, COBRAMED made a profit of €1,674.
Where can I find the annual accounts of COBRAMED?
COBRAMED filed 25 annual accounts with the National Bank of Belgium, the latest for financial year 2026.
When are the next annual accounts of COBRAMED due?
COBRAMED must file the annual accounts for financial year 2027 by 30-09-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.